Researchers at the Paul Scherrer Institute PSI have developed an AI that could open up a new, cost-effective approach to ...

At MIT, one genome researcher is testing a different approach. Bin Zhang, associate professor of chemistry and the leader of ...

Data presented at American Association for Cancer Research (AACR) Annual Meeting. In April 2025, Foghorn presented new preclinical data highlighting pipeline progress for potential first-in-class ...

The nuclear pore complex protein RANBP2 has emerged as a critical factor in the development and progression of various solid ...

In the earliest hours after fertilization, an embryo takes its first steps toward becoming a living organism by shedding ...

Researchers use generative AI to design synthetic enhancers that can effectively control gene expression in healthy mammalian cells.

Cell-free systems for single-copy genes in chromosomal ... will the last word on chromatin have been spoken.

The nuclear pore complex protein RANBP2 has emerged as a critical factor in the development and progression of various solid malignancies.

The nuclear pore complex protein RANBP2 has emerged as a critical factor in the development and progression of various solid malignancies. As a SUMO ...

Life depends on genes being switched on and off at exactly the right time. Even the simplest living organisms do this, but ...

A new study reveals that distal gene regulation via DNA looping evolved 150 million years earlier than previously believed.

Foghorn Therapeutics Inc.’s FHTX share price has surged by 5.95%, which has investors questioning if this is right time to sell.